Medicare Drug Prices
Sort by
137 items
Filter
Items per page
-
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
The decision is another win for the Biden administration in a bitter legal fight with several drugmakers over the constitutionality of the price talks.CNBC - Business -
Sanders launches investigation into 'unacceptable' diabetes, weight loss drug prices
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo Nordisk’s respective diabetes and weight loss drugs, ...The Hill - Politics -
Sanders locks onto next drug pricing target: Ozempic
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Sanders locks onto next drug pricing target: Ozempic After successfully getting manufacturers to lower the prices of insulin and inhalers, Sen. Bernie Sanders ...The Hill - Politics -
California moves to cut medicine prices with novel deal on opioid overdose drugs
US state to buy naloxone nasal spray from generics maker and distribute medication under its own brandFinancial Times - World - California -
Does Medicare pay for hearing aids?
Wondering if Medicare covers hearing aids? Learn more about which plans offer coverage for for hearing aids.CBS News - Top stories -
Does Medicare cover long-term care costs?
Are you relying on a Medicare policy to cover your long-term care costs? That may not be the best plan. Here's why.CBS News - Top stories -
The New Drug Threat
An investigation into the supply of illegal synthetic opioid drugs called nitazenes.BBC News - Top stories -
Some Older Women Need Extra Breast Scans. Why Won’t Medicare Pay?
Mammography can miss tumors in women with dense breasts, so their doctors often include ultrasound or M.R.I. scans. Patients often wind up paying the bill.The New York Times - Health -
Some Older Women Need Extra Breast Scans. Why Won’t Medicare Pay?
Mammography can miss tumors in women with dense breasts, so their doctors often include ultrasound or M.R.I. scans. Patients often wind up paying the bill.The New York Times - Science -
-
Biden grants clemency to 16 nonviolent drug offenders
"America is a nation founded on the promise of second chances," President Biden said in a statement.CBS News - Politics - Joe Biden -
Biden grants clemency to 16 nonviolent drug offenders
"America is a nation founded on the promise of second chances," President Biden said in a statement.CBS News - Politics - Joe Biden -
How one state is trying to make weight loss drugs cheaper
Weight loss drugs aren't covered by insurance for North Carolina's state employees. The state is negotiating with drugmakers Eli Lilly and Novo Nordisk to try to lower the costs.NBC News - Top stories -
Insurers scale back reimbursements for drugs used for weight loss
A growing number of insurance carriers say they won't cover the cost of weight loss medications because it is too high. The change is forcing some patients to take desperate measures. NBC News' Erin McLaughlin reports.NBC News - Top stories -
Meta proves AI hype has its limits
Artificial intelligence is a multibillion-dollar project with no clear timeline for revenuesFinancial Times - Business - Meta -
Zuckerberg defends Meta’s AI spending spree as shares tumble
Parent of Facebook and Instagram reports better than expected quarterly revenue but raises capex guidanceFinancial Times - Business -
Zuckerberg defends Meta’s AI spending spree as shares tumble
Parent of Facebook and Instagram reports better than expected quarterly revenue but raises capex guidanceFinancial Times - Business -
EveryONE Medicines: Designing Drugs for Rare Diseases, One at a Time
Khosla Ventures, GV, Third Rock Ventures back effort to create medicines for individual patients with rare central nervous system diseases.The Wall Street Journal - World -
For Beaten-Down Maker of Alzheimer's Drug, Good Enough Will Do
In-line sales for Alzheimer’s drug Leqembi and a beat for rare-disease drug Skyclarys has Wall Street giving Biogen another chance.The Wall Street Journal - World -
BHP plans £31bn bid for Anglo American but attracts ire from South Africa and shareholders
Legal & General and Abrdn criticise offer as undervaluing UK-listed minerFinancial Times - Business -
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
AbbVie on Friday reported first-quarter results that beat expectations even as sales of its blockbuster autoimmune drug Humira continued to fall.MarketWatch - Business -
British Columbia abruptly drops drug decriminalization after backlash
Premier asks government to reintroduce ban, ending Canada’s first large attempt to gauge effects of decriminalization . British Columbia has abruptly reversed course on its landmark experiment decriminalizing the possession of certain illicit ...The Guardian - World -
German Bund Yield Edges Higher on Two-Year High Consumer Sentiment Data
10-year Bund yields edged higher after an above-forecast GfK consumer sentiment index added to the better-than-expected German data this week.The Wall Street Journal - World -
BYD Seal 2024 Review: Prices, Specs, Availability
A world-class sedan for the people, from China’s biggest name in EVs. It’s here to best Elon’s offering, and it may well be the car to do it.Wired - Tech -
Gold's price is high. Is it still safe to invest in?
Gold has long been thought of as a safe investment. But is it still safe after recent price growth? Find out here.CBS News - Top stories -
CVC Soars in of Amsterdam Trading Debut
CVC shares rose 24% on the first day of trading on Amsterdam’s stock exchange, after the buyout firm priced its IPO at the mid point of its previously guided range, implying a market capitalization of $15 billion.The Wall Street Journal - World -
CVC Soars in of Amsterdam Trading Debut
CVC shares rose 24% on the first day of trading on Amsterdam’s stock exchange, after the buyout firm priced its IPO at the mid point of its previously guided range, implying a market capitalization of $15 billion.The Wall Street Journal - Business -
CVC shares jump in trading debut after long-awaited IPO
Private equity group says €2bn offering oversubscribed multiple times, in sign of strong investor appetiteFinancial Times - Business -
MTA’s Congestion Pricing in NYC Will Start June 30
Transit officials announced the start of the program, which they have said will ease some of the nation’s worst traffic.The New York Times - Top stories -
-
Salmond says independence plan is price for Yousaf support
The Alba leader demands the SNP focus on independence rather than "divisive" identity politics.BBC News - Top stories -
Comex Gold, Silver Settle Higher
Gold settled nearly 0.5% higher, up for three consecutive sessions, and silver rose 0.4%, up two of the past three sessions.The Wall Street Journal - World -
Rising Food Prices Send More Shoppers to Aldi
The German grocer keeps prices low with smaller stores, fewer staffers and a slimmer product menu than bigger supermarkets.The Wall Street Journal - World -
Rising Food Prices Send More Shoppers to Aldi
The German grocer keeps prices low with smaller stores, fewer staffers and a slimmer product menu than bigger supermarkets.The Wall Street Journal - Business -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
Malaria is still a significant public health challenge in Kenya, but an important pilot of the world’s first malaria vaccine may helpABC News - World -
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
Malaria is still a significant public health challenge in Kenya, but an important pilot of the world’s first malaria vaccine may helpABC News - Health